The role of NAFLD in extrahepatic malignancies: the importance of ruling out the effect of obesity

We read with great interests the article by Gi-Ae et al[1]. Non-alcoholic fatty liver disease(NAFLD) is strongly associated with metabolic disorders such as insulin resistance, diabetes and cardiovascular diseases which implies that NAFLD might have an important part in extrahepatic complications. Gi-Ae et al not only confirmed that NAFLD is closely related to the development of hepatocellular carcinoma but also demonstrated that NAFLD is a risk factor for extrahepatic malignancies such as male colorectal carcinoma and female breast cancer.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research

Related Links:

According to a recent study, almost one-third of Americans with prediabetes have arthritis. And half of these individuals with both conditions are physically inactive or have obesity.
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news
The imaging process provides the most time-efficient sequence with the highest lesion detection rate and conspicuity.
Source: Diagnostic Imaging - Category: Radiology Authors: Tags: MRI Prostate Cancer Source Type: news
(Reuters Health) - Workers with diabetes who switch to high-deductible health plans that require paying more out-of-pocket for care may be more likely than those who remain in low-deductible plans to delay needed checkups, a U.S. study suggests.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
The same smartphone technology that can recognize a user's face and voice can now identify breast cancer tumors, a recent study said.
Source: Health News - - Category: Consumer Health News Source Type: news
The American Cancer Society (ACS) National Lung Cancer Roundtable has launched...Read more on AuntMinnie.comRelated Reading: USPSTF opens review of CT lung screening guidance Kazerooni to chair ACS Lung Cancer Roundtable
Source: Headlines - Category: Radiology Source Type: news
When Alphabet’s Verily Lifesciences plunged into medtech the company took a deep dive. Some collaborations seemed futuristic and others were just natural. However, not all of the collaborations were going to be successful. And so, Verily, the former life sciences division of Google, along with Alcon, Novartis’ eyecare division, are putting the brakes on a plan for its smart lens to detect glucose levels. Brian Otis, PHD, Chief Technical Officer for Verily announced the news in a recent blog posting. “Our clinical work on the glucose-sensing lens demonstrated that there ...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Digital Health Source Type: news
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Today's open access paper is, I think, chiefly interesting for the later section in which the authors ponder future directions for the treatment of aging via means of destroying or manipulating the activity of senescent cells. The accumulation of senescent cells is one of the root causes of aging. The creation of senescent cells happens constantly in the undamaged and fully functional tissues of young people, a tiny fraction of these senescent cells manage to evade destruction and linger to cause issues, and given enough time that fraction will grow large enough to kill you. Cellular senescence isn't the only harmful cause...
Source: Fight Aging! - Category: Research Authors: Tags: Medicine, Biotech, Research Source Type: blogs
More News: Alcoholism | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Colorectal Cancer | Diabetes | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Gastroenterology | Heart | Hepatocellular Carcinoma | Insulin | Liver | Liver Cancer | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Urology & Nephrology